板塊輪動觀察 16/03/2023 關注股份📊 藥品:信達生物(1801)

港股短評

經過兩日上沖下洗之後,恆指回穩,昨日最高曾高見19745,其後回順至19539點收市。市場開始消化美國矽谷銀行的負面影響,不過瑞信事件又刮起另一股寒風,夜期曾跌至19025點,雖然尾市回升至19230 ,留意250天線未能收復,大市再度尋底的機會較大。

https://business.facebook.com/%E8%82%A1%E4%BD%A0%E5%94%94%E5%88%B0-232673967110384/

 

以上內容並非亦不應被視為投資建議,只作為資料性及一般用途,投資者應考慮自己個人需要、投資目標及特定財政狀況,本內容不構成據以所作任何行動的要約、邀請、建議或招攬。

Facebook
WhatsApp
Twitter

Notification


About false information on the internet

Recent spreading false information on some social platforms, including statement that Silverbricks Securities is unable to withdraw funds and has subscribed for the initial public offering of Guomai Culture&Media Co.,Ltd. (301052). We, hereby, make the following declaration .

Our company is supervised by the Securities and Futures Commission of Hong Kong(SFC). Our finances are sound and has no issues with deposits and withdrawals. Meanwhiles, we does not subscribe any shares of Guomai Culture&Media Co.,Ltd. (301052)

Our company condemns this untrue remarks and reserves the right to pursue legal liabilities. If customers have any questions, please call our company for inquiries, Tel: 3998 5120

元库证券有限公司

SILVERBRICKS SECURITIES COMPANY LIMITED